4/A: Omada Health Insider Trades Correction

Omada Health's Chief Accounting Officer, Craig Gracey, filed a Form 4/A to correct previously omitted stock option exercise transactions.

Summary

• Craig Gracey, Chief Accounting Officer at Omada Health, Inc., filed a Form 4/A on July 8, 2026, to amend a previous Form 4 filed on June 30, 2026.
• The amendment corrects inadvertently omitted transactions related to the exercise of stock options.
• These exercises were part of same-day exercise-and-sale transactions, with the sales having been timely reported in the original Form 4.
• The omission led to an understatement of the securities beneficially owned following the sales, which has now been adjusted.
• Specifically, 2,084 shares were exercised on June 26, 2026, and 2,083 shares on June 29, 2026, under a 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing; it's a procedural correction of an administrative error rather than a reflection of new company performance or strategy.

Positives

• The filing corrects an administrative error, ensuring accurate reporting of beneficial ownership.
• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-sensitive trading activity.
• The underlying sales transactions were reported on time, mitigating concerns about undisclosed sales.

Negatives

• The original filing contained an omission, leading to an inaccurate representation of beneficial ownership until this amendment.
• The exercise of stock options at $6.57 per share and subsequent sale at prices between $20 and $21 indicates a profitable transaction for the insider, but the initial omission is a procedural negative.

Risks

• Potential for scrutiny regarding the accuracy and completeness of initial SEC filings.
• The reliance on 10b5-1 plans, while providing a defense, still involves insider transactions that can be perceived negatively by the market if not managed transparently.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it is an amendment to correct past transactions.

Management Comments

• "This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing."
• "The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4."
• "Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error."

Industry Context

StockSavvy.ai notes that amendments to Form 4 filings, while procedural, highlight the importance of meticulous record-keeping and timely disclosure in the life sciences sector, where insider transactions are closely watched.

Stakeholder Impact

• Shareholders: The amendment corrects an understatement of beneficial ownership, providing a more accurate picture of insider holdings. The underlying sales were already reported, so the immediate market impact is likely minimal.
• Management: Highlights the need for rigorous internal controls to ensure accurate and timely SEC filings.

Next Steps

• Ensure all future filings are accurate and complete to avoid further amendments.
• Continue to monitor Omada Health's disclosures for any material updates.

Key Dates

Keywords

Form 4/A, Omada Health, Insider Trading, Stock Options, Beneficial Ownership, 10b5-1 Plan, SEC Filing, Amendment, Craig Gracey